A verified NAD+ certificate of analysis (COA) provides critical quantitative data confirming the chemical identity, purity, and safety profile of nicotinamide adenine dinucleotide for laboratory research. Evaluated via high-performance liquid chromatography (HPLC), mass spectrometry (MS), and bacterial endotoxin testing, third-party analytical documentation ensures batch-to-batch consistency and accuracy in cellular in vitro assays and preclinical models.
A verified NAD+ certificate of analysis (COA) provides critical quantitative data confirming the chemical identity, purity, and safety profile of nicotinamide adenine dinucleotide for laboratory research. Evaluated via high-performance liquid chromatography (HPLC), mass spectrometry (MS), and bacterial endotoxin testing, third-party analytical documentation ensures batch-to-batch consistency and accuracy in cellular in vitro assays and preclinical models.
In analytical biochemistry and preclinical investigation, a Certificate of Analysis (COA) serves as the primary empirical verification of a chemical compound's identity, purity, and structural integrity. For coenzymes like NAD+ (nicotinamide adenine dinucleotide), securing a comprehensive COA is essential prior to initiating in vitro protocols or enzyme kinetics studies. Because metabolic cofactors can degrade under improper storage or synthesis conditions, relying on rigorous analytical documentation ensures that experimental results remain reproducible and unconfounded by impurities.
A robust **nad+ certificate of analysis** provides detailed lot-specific metrics generated by independent testing facilities. Key analytical parameters reported include chemical identity confirmation via mass spectrometry, purity percentages determined by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), residual solvent analysis, heavy metal testing, and bacterial endotoxin assays. Researchers accessing the PX1 Research research library can review documentation establishing these strict quality standards across all production lots.
When examining an **nad coa**, the RP-HPLC chromatogram represents the core baseline of compound purity. Liquid chromatography separates the target molecule from potential synthesis byproducts, structural isomers, and oxidation degradation products based on their hydrophobic interactions with the column stationary phase. In a standard RP-HPLC profile for nicotinamide adenine dinucleotide, the primary analyte peak should demonstrate sharp symmetry with minimal tailing.
Purity is quantified through peak area integration, calculating the percentage of total chromatogram area occupied by the target compound relative to trace impurities. For laboratory-grade reagents available in our all peptides catalog, PX1 Research enforces a strict purity threshold—typically ≥98.0% by HPLC. Chromatographic conditions, including mobile phase composition (e.g., trifluoroacetic acid in acetonitrile/water gradient), flow rates, and UV detection wavelengths (typically 260 nm for pyridine nucleotides), must be fully detailed on the COA to validate the analytical method.
While RP-HPLC establishes chemical purity, mass spectrometry is necessary to confirm molecular mass and chemical identity. Electrospray Ionization Mass Spectrometry (ESI-MS) is the standard method used to analyze non-volatile coenzymes and peptides. An authentic **nad+ certificate of analysis** will include the observed mass-to-charge ratio (m/z) alongside the theoretical molecular weight of the oxidized dinucleotide (C21H27N7O14P2, theoretical mass ~663.43 g/mol).
The presence of a dominant single peak at the expected m/z value confirms that the batch consists of the intact nicotinamide adenine dinucleotide structure without significant molecular fragmentations or unexpected substitutions. In contrast, improper handling or thermal degradation may yield breakdown products such as free nicotinamide or ADP-ribose, which are readily identified as anomalous peaks on the ESI-MS spectrum.
In cell culture studies, isolated organ preparations, and animal models, bacterial endotoxins (lipopolysaccharides derived from Gram-negative bacterial outer membranes) can induce unwanted inflammatory signaling and alter cellular responses. Consequently, evaluating endotoxin levels is a critical step when reviewing an **nad coa** for preclinical application.
Endotoxin testing is typically conducted using the Limulus Amebocyte Lysate (LAL) chromogenic assay or kinetic turbidimetric method. High-purity reagents supplied for laboratory research must maintain endotoxin concentrations below stringent thresholds, typically <0.01 EU/mg or strictly defined batch limits. Verified endotoxin documentation prevents non-specific immunological activation in cell assays, preserving the integrity of experimental findings.
Laboratory managers and principal investigators evaluating vendors for research compounds should verify that certificates of analysis meet transparent, standardized criteria. Relying on self-issued vendor statements without independent lab validation introduces significant experimental risk. PX1 Research mandates that every batch undergoes verified testing prior to release.
The critical criteria for evaluating an analytical testing report include:
• Third-Party Independent Verification: Testing must be conducted by ISO 17025-accredited analytical laboratories detached from the manufacturing line.
• Lot Traceability: The lot number listed on the COA must directly match the vial label received in the shipment.
• Unredacted Chromatograms: Clear visual representation of HPLC integration baselines and ESI-MS spectra without obscured axis data.
• Quantitative Endotoxin Testing: Explicit numerical results in EU/mg rather than vague 'pass' designations.
• USA Manufacturing Standards: Synthesis and lyophilization conducted in GMP-compliant domestic facilities.
For labs requiring bulk quantities or recurring institutional orders, our wholesale research accounts provide direct access to lot-specific analytical archives and batch certificates.
Nicotinamide adenine dinucleotide operates within a broader network of metabolic coenzymes, mitochondrial signaling compounds, and regulatory peptides studied in cellular biology. Comparing the structural stability and analytical profiles of these reagents helps researchers select the appropriate compound for specific in vitro assays.
For example, researchers exploring dinucleotide precursor pathways frequently evaluate NMN (nicotinamide mononucleotide) alongside direct NAD+ formulations. Similarly, studies investigating cellular redox balance often pair NAD+ protocols with glutathione, a major endogenous antioxidant co-factor. In mitochondrial bioenergetics research, investigators may compare coenzyme activity against specialized peptide vectors like MOTS-c or metabolic modulators such as CJC-1295 No DAC. Reviewing accurate COAs across each of these research compounds ensures precise molar calculations and consistent assay conditions.
To maintain the analytical specifications confirmed on the **nad+ certificate of analysis**, proper laboratory handling and reconstitution procedures must be strictly maintained. Lyophilized NAD+ is hygroscopic and sensitive to temperature variations, light exposure, and aqueous hydrolysis.
Upon receipt, lyophilized vials should be stored at -20°C or -80°C in a desiccated environment. For in vitro experimentation, reconstitution should be performed using sterile laboratory solvents such as nuclease-free water or buffered saline (PBS). Because aqueous NAD+ solutions undergo gradual hydrolysis over time, reconstituted aliquots should be prepared immediately prior to use or stored at -80°C to minimize degradation. Avoiding repeated freeze-thaw cycles preserves coenzyme activity and prevents peak broadening in subsequent analytical assays.
PX1 Research is dedicated to supplying highest-grade reagents manufactured exclusively in USA-based, GMP-compliant facilities. Every lot of NAD+ undergoes exhaustive quality control procedures before distribution, guaranteeing that the physical product matches the attached **nad coa** exactly.
Orders placed before deadline ship the same day from our logistics hubs in California and Arizona (M–F), packaged in insulated, temperature-controlled containers to maintain compound stability during transit. By adhering to rigorous ISO 17025 analytical standards and providing transparent batch documentation, PX1 Research remains a trusted supplier for academic, biotechnological, and institutional research facilities nationwide.
Where can I view the nad+ certificate of analysis for a specific batch?
Batch-specific certificates of analysis are accessible directly on the PX1 Research product page for NAD+. Researchers can view and download full analytical reports, including unredacted RP-HPLC chromatograms and mass spectrometry data, corresponding to their active lot number.
What does a typical nad coa report include?
An authentic NAD COA reports RP-HPLC purity percentage, mass confirmation via ESI-MS (observed m/z), bacterial endotoxin levels (LAL assay), visual appearance, solubility properties, and lot traceability numbers linked to ISO 17025 accredited laboratory testing.
What purity level is required for in vitro NAD+ research?
Most preclinical cellular assays and enzymatic studies require a minimum purity threshold of ≥98.0% by RP-HPLC to ensure that degradation products (such as free nicotinamide or ADP-ribose) do not interfere with kinetic readings.
How is the molecular identity of NAD+ confirmed on a COA?
Molecular identity is confirmed using Electrospray Ionization Mass Spectrometry (ESI-MS). The COA displays an observed molecular weight matching the theoretical mass (~663.43 g/mol) of the oxidized nicotinamide adenine dinucleotide ion.
Why is endotoxin testing critical for research-grade NAD+?
Endotoxins (lipopolysaccharides) provoke immune responses in cell cultures and animal tissue models. Verifying low endotoxin levels (<0.01 EU/mg) ensures that cellular responses observed during experiments are attributed solely to the test compound.
How should lyophilized NAD+ be stored upon arrival?
Lyophilized NAD+ should be stored desiccated at -20°C or -80°C upon arrival. Reconstituted aqueous solutions should be aliquoted and stored at -80°C to prevent hydrolysis and structural breakdown.
Are PX1 Research compounds suitable for human consumption or therapeutic use?
No. All compounds supplied by PX1 Research are strictly intended for laboratory research, in vitro experimentation, and preclinical scientific study. They are not for human or veterinary medical use, injection, or consumption.
What solvents are recommended for reconstituting NAD+ in the laboratory?
NAD+ is soluble in sterile laboratory-grade water or phosphate-buffered saline (PBS). Solvents should be sterile and endotoxin-free to maintain the purity metrics documented on the certificate of analysis.
Where are PX1 Research products manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based, GMP-compliant facilities. Orders are processed and dispatched same-day (Monday through Friday) from our fulfillment centers in California and Arizona.
How can institutional laboratories apply for bulk ordering or wholesale pricing?
Institutional accounts, university laboratories, and commercial research entities can apply for high-volume pricing through our wholesale application page at /wholesale.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.